575 related articles for article (PubMed ID: 15378019)
1. AP-1 blockade in breast cancer cells causes cell cycle arrest by suppressing G1 cyclin expression and reducing cyclin-dependent kinase activity.
Liu Y; Lu C; Shen Q; Munoz-Medellin D; Kim H; Brown PH
Oncogene; 2004 Oct; 23(50):8238-46. PubMed ID: 15378019
[TBL] [Abstract][Full Text] [Related]
2. The AP-1 transcription factor regulates breast cancer cell growth via cyclins and E2F factors.
Shen Q; Uray IP; Li Y; Krisko TI; Strecker TE; Kim HT; Brown PH
Oncogene; 2008 Jan; 27(3):366-77. PubMed ID: 17637753
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of AP-1 transcription factor causes blockade of multiple signal transduction pathways and inhibits breast cancer growth.
Liu Y; Ludes-Meyers J; Zhang Y; Munoz-Medellin D; Kim HT; Lu C; Ge G; Schiff R; Hilsenbeck SG; Osborne CK; Brown PH
Oncogene; 2002 Oct; 21(50):7680-9. PubMed ID: 12400010
[TBL] [Abstract][Full Text] [Related]
4. Retinoic acid inhibition of cell cycle progression in MCF-7 human breast cancer cells.
Zhu WY; Jones CS; Kiss A; Matsukuma K; Amin S; De Luca LM
Exp Cell Res; 1997 Aug; 234(2):293-9. PubMed ID: 9260897
[TBL] [Abstract][Full Text] [Related]
5. BRCA1 proteins are transported to the nucleus in the absence of serum and splice variants BRCA1a, BRCA1b are tyrosine phosphoproteins that associate with E2F, cyclins and cyclin dependent kinases.
Wang H; Shao N; Ding QM; Cui J; Reddy ES; Rao VN
Oncogene; 1997 Jul; 15(2):143-57. PubMed ID: 9244350
[TBL] [Abstract][Full Text] [Related]
6. cFos is critical for MCF-7 breast cancer cell growth.
Lu C; Shen Q; DuPré E; Kim H; Hilsenbeck S; Brown PH
Oncogene; 2005 Sep; 24(43):6516-24. PubMed ID: 16027729
[TBL] [Abstract][Full Text] [Related]
7. Apigenin inhibits growth and induces G2/M arrest by modulating cyclin-CDK regulators and ERK MAP kinase activation in breast carcinoma cells.
Yin F; Giuliano AE; Law RE; Van Herle AJ
Anticancer Res; 2001; 21(1A):413-20. PubMed ID: 11299771
[TBL] [Abstract][Full Text] [Related]
8. c-myc-enhanced S phase entry in keratinocytes is associated with positive and negative effects on cyclin-dependent kinases.
Alexandrow MG; Moses HL
J Cell Biochem; 1998 Sep; 70(4):528-42. PubMed ID: 9712150
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of cell-cycle effectors of proliferation in bladder tumor epithelial cells by the p75NTR tumor suppressor.
Khwaja F; Djakiew D
Mol Carcinog; 2003 Mar; 36(3):153-60. PubMed ID: 12619038
[TBL] [Abstract][Full Text] [Related]
10. Vitamin E succinate inhibits proliferation of BT-20 human breast cancer cells: increased binding of cyclin A negatively regulates E2F transactivation activity.
Turley JM; Ruscetti FW; Kim SJ; Fu T; Gou FV; Birchenall-Roberts MC
Cancer Res; 1997 Jul; 57(13):2668-75. PubMed ID: 9205075
[TBL] [Abstract][Full Text] [Related]
11. Over-expression of insulin-like growth factor binding protein-related protein-1(IGFBP-rP1/mac25) in the M12 prostate cancer cell line alters tumor growth by a delay in G1 and cyclin A associated apoptosis.
Sprenger CC; Vail ME; Evans K; Simurdak J; Plymate SR
Oncogene; 2002 Jan; 21(1):140-7. PubMed ID: 11791184
[TBL] [Abstract][Full Text] [Related]
12. Bone morphogenetic protein-2 induces hypophosphorylation of Rb protein and repression of E2F in androgen-treated LNCaP human prostate cancer cells.
Tomari K; Kumagai T; Shimizu T; Takeda K
Int J Mol Med; 2005 Feb; 15(2):253-8. PubMed ID: 15647840
[TBL] [Abstract][Full Text] [Related]
13. [G1 block of the cell cycle during differentiation of F9 cells correlates with accumulation of inhibitors of the activity of cyclin-kinase complexes of proteins p21/Waf1 and p27/Kip].
Malashicheva AB; Kisliakova TV; Pospelov VA
Tsitologiia; 2002; 44(7):649-55. PubMed ID: 12455373
[TBL] [Abstract][Full Text] [Related]
14. Blockade of AP-1 activity by dominant-negative TAM67 can abrogate the oncogenic phenotype in latent membrane protein 1-positive human nasopharyngeal carcinoma.
Jin X; Song X; Li L; Wang Z; Tao Y; Deng L; Tang M; Yi W; Cao Y
Mol Carcinog; 2007 Nov; 46(11):901-11. PubMed ID: 17477349
[TBL] [Abstract][Full Text] [Related]
15. Ectopic expression of cyclin E in estrogen responsive cells abrogates antiestrogen mediated growth arrest.
Dhillon NK; Mudryj M
Oncogene; 2002 Jul; 21(30):4626-34. PubMed ID: 12096339
[TBL] [Abstract][Full Text] [Related]
16. Deregulated expression of cell-cycle proteins during premalignant progression in SENCAR mouse skin.
Rodriguez-Puebla ML; LaCava M; Gimenez-Conti IB; Johnson DG; Conti CJ
Oncogene; 1998 Oct; 17(17):2251-8. PubMed ID: 9811455
[TBL] [Abstract][Full Text] [Related]
17. Anticarcinogenic effect of a flavonoid antioxidant, silymarin, in human breast cancer cells MDA-MB 468: induction of G1 arrest through an increase in Cip1/p21 concomitant with a decrease in kinase activity of cyclin-dependent kinases and associated cyclins.
Zi X; Feyes DK; Agarwal R
Clin Cancer Res; 1998 Apr; 4(4):1055-64. PubMed ID: 9563902
[TBL] [Abstract][Full Text] [Related]
18. Activation of c-Myc uncouples DNA replication from activation of G1-cyclin-dependent kinases.
Pusch O; Bernaschek G; Eilers M; Hengstschläger M
Oncogene; 1997 Aug; 15(6):649-56. PubMed ID: 9264405
[TBL] [Abstract][Full Text] [Related]
19. Rb dephosphorylation and suppression of E2F activity in human breast tumor cells exposed to a pharmacological concentration of estradiol.
Gewirtz DA; Di YM; Randolph JK; Jain PT; Valerie K; Bullock S; Nath N; Chellappan SP
Arch Biochem Biophys; 2001 Apr; 388(2):243-52. PubMed ID: 11368161
[TBL] [Abstract][Full Text] [Related]
20. AP-1 blockade inhibits the growth of normal and malignant breast cells.
Ludes-Meyers JH; Liu Y; Muñoz-Medellin D; Hilsenbeck SG; Brown PH
Oncogene; 2001 May; 20(22):2771-80. PubMed ID: 11420689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]